Clinical Trial Update: Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CAPTEM to FOLFIRI as second-line treatment in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CAPTEM (CAPTEM)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED